News related to Reyataz (Atazanavir) and/or conditions it is approved for
EMA Panel Recommends Evotaz for Adults With HIV-1
Source: Medscape HIV/AIDS Headlines [2015.05.22]
An EMA panel has recommended marketing authorization for atazanavir/cobicistat for the treatment of adults with HIV-1 infection and no known mutations associated with atazanavir resistance.
Health and social inequities drives HIV in young men who have sex with other men
Source: HIV / AIDS News From Medical News Today [2015.05.20]
In addition, younger average age at sexual debut with another man was also associated with a greater likelihood of HIV seroconversionHIV infections continue to rise in a new generation of young...